ClinicalTrials.Veeva

Menu

Stool Collection Sub-Study of Exact Sciences Protocol 2018-01

Exact Sciences Corporation logo

Exact Sciences Corporation

Status

Completed

Conditions

Colo-rectal Cancer
Cancer
Colorectal Cancer

Treatments

Other: Stool Sample Collection

Study type

Observational

Funder types

Industry

Identifiers

NCT04473625
2018-01B

Details and patient eligibility

About

The primary objective of this sub-study is to obtain de-identified, clinically characterized, stool specimens from subjects with untreated solid tumors for research use in the development and validation of a stool-based test for colorectal cancer.

Enrollment

291 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Subject is currently enrolled in Exact Sciences Protocol 2018-01.
  • Subject is willing and able to provide a stool sample.
  • Subject understands the study procedures and is able to provide written informed consent to participate in the study.

Exclusion criteria

  • Subject has a condition the Investigator believes would interfere with his or her ability to provide informed consent, comply with the sub-study protocol, or put the person at undue risk.

Trial design

291 participants in 12 patient groups

Breast
Description:
Subjects with clinically confirmed breast cancer and who are treatment naive will provide a stool sample within 30 days of enrollment. No additional stool sample collections will occur.
Treatment:
Other: Stool Sample Collection
Lung
Description:
Subjects with clinically confirmed lung cancer and who are treatment naive will provide a stool sample within 30 days of enrollment. No additional stool sample collections will occur.
Treatment:
Other: Stool Sample Collection
Colorectal
Description:
Subjects with clinically confirmed colorectal cancer and who are treatment naive will provide a stool sample within 30 days of enrollment. No additional stool sample collections will occur.
Treatment:
Other: Stool Sample Collection
Prostate
Description:
Subjects with clinically confirmed prostate cancer and who are treatment naive will provide a stool sample within 30 days of enrollment. No additional stool sample collections will occur.
Treatment:
Other: Stool Sample Collection
Bladder
Description:
Subjects with clinically confirmed or suspicion of bladder cancer and who are treatment naive will provide a stool sample within 30 days of enrollment. No additional stool sample collections will occur.
Treatment:
Other: Stool Sample Collection
Uterine
Description:
Subjects with clinically confirmed uterine cancer and who are treatment naive will provide a stool sample within 30 days of enrollment. No additional stool sample collections will occur.
Treatment:
Other: Stool Sample Collection
Kidney/Renal Pelvis
Description:
Subjects with clinically confirmed or suspicion of kidney/renal pelvis cancer and who are treatment naive will provide a stool sample within 30 days of enrollment. No additional stool sample collections will occur.
Treatment:
Other: Stool Sample Collection
Ovarian
Description:
Subjects with clinically confirmed or suspicion of ovarian cancer and who are treatment naive will provide a stool sample within 30 days of enrollment. No additional stool sample collections will occur.
Treatment:
Other: Stool Sample Collection
Liver
Description:
Subjects with clinically confirmed liver cancer and who are treatment naive will provide a stool sample within 30 days of enrollment. No additional stool sample collections will occur.
Treatment:
Other: Stool Sample Collection
Pancreas
Description:
Subjects with clinically confirmed or suspicion of pancreatic cancer and who are treatment naive will provide a stool sample within 30 days of enrollment. No additional stool sample collections will occur.
Treatment:
Other: Stool Sample Collection
Stomach
Description:
Subjects with clinically confirmed stomach cancer and who are treatment naive will provide a stool sample within 30 days of enrollment. No additional stool sample collections will occur.
Treatment:
Other: Stool Sample Collection
Esophageal
Description:
Subjects with clinically confirmed esophageal cancer and who are treatment naive will provide a stool sample within 30 days of enrollment. No additional stool sample collections will occur.
Treatment:
Other: Stool Sample Collection

Trial contacts and locations

12

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems